Leukopenia News and Research

RSS
Leukopenia is a decrease in the number of white blood cells (leukocytes) found in the blood, which places individuals at increased risk of infection.
Genmab reports top-line interim results from ofatumumab Phase II study in Diffuse Large B-Cell Lymphoma

Genmab reports top-line interim results from ofatumumab Phase II study in Diffuse Large B-Cell Lymphoma

Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released

Pivotal PINNACLE trial results of VELCADE in patients with relapsed/refractory MCL released

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

Cytrx’s tamibarotene achieves molecular complete remission in advanced acute promyelocytic leukemia

Eisai reports preliminary results from Dacogen for Injection Phase III study in AML

Eisai reports preliminary results from Dacogen for Injection Phase III study in AML

SuperGen encouraged by Eisai's intent to file Dacogen sNDA for new indication

SuperGen encouraged by Eisai's intent to file Dacogen sNDA for new indication

CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets

CHMP adopts positive opinion on pending MAA for SYCREST sublingual tablets

FDA approves Jevtana to treat men with prostate cancer

FDA approves Jevtana to treat men with prostate cancer

FDA approves Jevtana in combination with prednisone for metastatic hormone-refractory prostate cancer

FDA approves Jevtana in combination with prednisone for metastatic hormone-refractory prostate cancer

Cell Therapeutics presents data on PIX301 trial of Pixuvri for relapsed or refractory, aggressive NHL

Cell Therapeutics presents data on PIX301 trial of Pixuvri for relapsed or refractory, aggressive NHL

Aeterna Zentaris presents positive data from AEZS-108 Phase 2 study in ovarian cancer at ASCO 2010

Aeterna Zentaris presents positive data from AEZS-108 Phase 2 study in ovarian cancer at ASCO 2010

Novartis' Afinitor decreases size of SEGAs associated with tuberous sclerosis

Novartis' Afinitor decreases size of SEGAs associated with tuberous sclerosis

Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations

Millennium reports on data of VELCADE for multiple myeloma from 2010 ASCO oral presentations

Millennium announces data on VELCADE in treatment of patients with amyloidosis

Millennium announces data on VELCADE in treatment of patients with amyloidosis

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

New data highlighting Pfizer's approach to cancer drug development to be presented at ASCO meeting

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

Takeda enters co-promotion agreement with Janssen Pharma for VELCADE

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

New data on Cimzia for Crohn’s Disease treatment to be demonstrated at DDW 2010

Study finds rapid epidemiological shift in HAV infection in Korea

Study finds rapid epidemiological shift in HAV infection in Korea

Eisai's Dacogen five-day dosing regimen for treatment of MDS receives FDA approval

Eisai's Dacogen five-day dosing regimen for treatment of MDS receives FDA approval

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

Novartis' Tasigna capsules granted priority review by FDA for treatment of adult patients with Ph+ CML

FDA approves Rituxan-FC combination therapy for CLL

FDA approves Rituxan-FC combination therapy for CLL